CANDID is a national study with practices participating from across the country, supported by the relevant local Clinical Research Network (CRN). Other regions have been able to successfully recruit to CANDID and, together with the national team, we are identifying factors that may help to support recruitment in our area. 

Now Recruiting Locally

Recruitment for CANDID in CRN West Midlands has begun. In our locality four practices are awaiting their first eligible patient. A further six practices are in the set-up stage and practice expressions of interest in the study are steadily increasing.

We are able to supply practices with a range of hints and tips, study posters etc., to support recruitment. Practices may invite patients with a broad spectrum of lung or bowel symptoms, which is important for developing future guidance that can distinguish between people at very low risk versus increased risk of cancer.

Separate research sessions (e.g. one hour to schedule three CANDID patients) have been shown to work well in practices that are recruiting successfully as this allows sufficient time to discuss the study with patients and to complete study documentation.

How can we help?

Materials and support for recruiting patients via monthly retrospective searches (selecting ten eligible patients who consulted in the previous week) is currently being tested; we will offer this to practices soon.

Our target for case identification is 1-2 participants per month per clinician to enable us to make a significant contribution towards the national target and we will be updating practices regularly to monitor progress in this important study.

Your local team are here to support you and answer any questions you may have. Please contact Julie Roscoe email j.roscoe@warwick.ac.uk or Jenny Lee, email: jennifer.lee@warwick.ac.uk if you have any queries about the CANDID study.